BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T. Beyond the tumour microenvironment. Int J Cancer 2019;145:2611-8. [PMID: 30989643 DOI: 10.1002/ijc.32343] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Hurdogan O, De Logu F, Galli F, Tuncer S, Ugolini F, Simi S, Portelli F, Nassini R, Massi D, Buyukbabani N. Digital Quantification of Intratumoral CD8+ T-Cells Predicts Relapse and Unfavorable Outcome in Uveal Melanoma. Cancers 2022;14:5959. [DOI: 10.3390/cancers14235959] [Reference Citation Analysis]
2 Ma Y, Zhan L, Yang J, Zhang J. SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.984555] [Reference Citation Analysis]
3 Wang L, Luo S, Wang Z, Huang Y, Luo Y, Xie X. Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer. Journal of Immunology Research 2022;2022:1-14. [DOI: 10.1155/2022/5160705] [Reference Citation Analysis]
4 Wu M, Bao J, Lei Y, Tao S, Lin Q, Chen L, Jin Y, Ding X, Yan Y, Han P. Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma. Front Oncol 2022;12:935672. [DOI: 10.3389/fonc.2022.935672] [Reference Citation Analysis]
5 Su X, Gao H, Qi Z, Xu T, Wang G, Luo H, Cheng P. Prediction of immune subtypes and overall survival in lung squamous cell carcinoma. Curr Med Res Opin 2022;:1-22. [PMID: 36245361 DOI: 10.1080/03007995.2022.2129231] [Reference Citation Analysis]
6 Handoko, Louisa M, Permata TBM, Gondhowiardjo SA. Deciphering Driver of Nasopharyngeal Cancer Development. Oncol Rev 2022;16:10654. [DOI: 10.3389/or.2022.10654] [Reference Citation Analysis]
7 Hu R, Liang X, Li Q, Liu Y, Shi Z. Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/4869732] [Reference Citation Analysis]
8 Wu Z, Yu X, Zhang S, He Y, Guo W. Mechanism underlying circRNA dysregulation in the TME of digestive system cancer. Front Immunol 2022;13:951561. [DOI: 10.3389/fimmu.2022.951561] [Reference Citation Analysis]
9 Zhu Y, Lin X, Zhou X, Prochownik EV, Wang F, Li Y. Posttranslational control of lipogenesis in the tumor microenvironment. J Hematol Oncol 2022;15:120. [PMID: 36038892 DOI: 10.1186/s13045-022-01340-1] [Reference Citation Analysis]
10 Kraiger M, Klein-Rodewald T, Rathkolb B, Calzada-Wack J, Sanz-Moreno A, Fuchs H, Wolf E, Gailus-Durner V, de Angelis MH. Monitoring longitudinal disease progression in a novel murine Kit tumor model using high-field MRI. Sci Rep 2022;12:14608. [PMID: 36028522 DOI: 10.1038/s41598-022-17880-y] [Reference Citation Analysis]
11 Wang Y, Feng W, Wang X, Li X, Mou Y, Wang X, Zhang Y. The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art. Biomed Pharmacother 2022;154:113575. [PMID: 35988422 DOI: 10.1016/j.biopha.2022.113575] [Reference Citation Analysis]
12 Tang X, Qi C, Zhou H, Liu Y. A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma. Heliyon 2022;8:e10164. [PMID: 36016532 DOI: 10.1016/j.heliyon.2022.e10164] [Reference Citation Analysis]
13 Li M, Wang Z, Dong S, Xu Y, Wang F. NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer. Journal of Immunology Research 2022;2022:1-19. [DOI: 10.1155/2022/8337048] [Reference Citation Analysis]
14 Zach M. A Complementary Account of Scientific Modelling: Modelling Mechanisms in Cancer Immunology. The British Journal for the Philosophy of Science. [DOI: 10.1086/721530] [Reference Citation Analysis]
15 Zheng Z, Zhang X, Bai J, Long L, Liu D, Zhou Y. PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway. Cancer Cell Int 2022;22:201. [PMID: 35614441 DOI: 10.1186/s12935-022-02545-7] [Reference Citation Analysis]
16 Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis]
17 Blaye C, Boyer T, Peyraud F, Domblides C, Larmonier N. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers. Front Immunol 2022;13:838040. [PMID: 35309358 DOI: 10.3389/fimmu.2022.838040] [Reference Citation Analysis]
18 Deng X, Xie Y, Lu Y, Li X, Guo X, Huang X, Lan X, Lin J, Tan W, Wang C. Jianpi Huayu Decoction enhances the effect of sorafenib and alleviates adverse events in hepatocellular carcinoma by remodeling the gut microbiota. Pharmacological Research - Modern Chinese Medicine 2022;2:100057. [DOI: 10.1016/j.prmcm.2022.100057] [Reference Citation Analysis]
19 Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs. Int J Biol Sci 2022;18:43-64. [PMID: 34975317 DOI: 10.7150/ijbs.62602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bremer A, Wik E, Akslen LA. HER2 Revisited: Reflections on the Future of Cancer Biomarker Research. Human Perspectives in Health Sciences and Technology 2022. [DOI: 10.1007/978-3-030-92612-0_7] [Reference Citation Analysis]
21 Militello G, Bertolaso M. The Complexity of Tumor Heterogeneity: Limitations and Challenges of the Pharmacogenomics in Cancer Treatment. Personalized Medicine in the Making 2022. [DOI: 10.1007/978-3-030-74804-3_2] [Reference Citation Analysis]
22 Anitha J, Selvakumar R, Hema S, Murugan K, Premkumar T. Facile green synthesis of nano-sized ZnO using leaf extract of Morinda tinctoria: MCF-7 cell cycle arrest, antiproliferation, and apoptosis studies. Journal of Industrial and Engineering Chemistry 2022;105:520-9. [DOI: 10.1016/j.jiec.2021.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bueschbell B, Caniceiro AB, Suzano PM, Machuqueiro M, Rosário-ferreira N, Moreira IS. Network Biology and Artificial Intelligence Drive the Understanding of the Multidrug Resistance Phenotype in Cancer. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Green S, Dam MS, Svendsen MN. Patient-Derived Organoids in Precision Oncology – Towards a Science of and for the Individual? Personalized Medicine in the Making 2022. [DOI: 10.1007/978-3-030-74804-3_7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Russo E, Boem F, Curini L, Amedei A. Gastrointestinal Cancers: What Is the Real Board of Microenvironment and the Role of Microbiota–Immunity Axis? Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_6] [Reference Citation Analysis]
26 Yi J, Zhong W, Wu H, Feng J, Zouxu X, Huang X, Li S, Shuang Z. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer. Front Oncol 2021;11:746058. [PMID: 34745969 DOI: 10.3389/fonc.2021.746058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kaminski H, Lemoine M, Pradeu T. Immunological exhaustion: How to make a disparate concept operational? PLoS Pathog 2021;17:e1009892. [PMID: 34555119 DOI: 10.1371/journal.ppat.1009892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
28 Luo Y, Yin S, Lu J, Zhou S, Shao Y, Bao X, Wang T, Qiu Y, Yu H. Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment. Cancer Cell Int 2021;21:386. [PMID: 34284780 DOI: 10.1186/s12935-021-02085-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Tu SJ, Tran VT, Teo JM, Chong WC, Tseng JR. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous 11 C-choline PET/MRI acquisition in prostate cancer patients. Med Phys 2021. [PMID: 34214211 DOI: 10.1002/mp.15064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
30 Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Front Immunol 2021;12:653836. [PMID: 33897701 DOI: 10.3389/fimmu.2021.653836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
31 Zharinov GM, Khalchitsky SE, Loktionov A, Sogoyan MV, Khutoryanskaya YV, Neklasova NY, Bogomolov OA, Smirnov IV, Samoilovich MP, Skakun VN, Vissarionov SV, Anisimov VN. The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia. Oncotarget 2021;12:698-707. [PMID: 33868590 DOI: 10.18632/oncotarget.27921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Lipinski S, Tiemann K. Extracellular Vesicles and Their Role in the Spatial and Temporal Expansion of Tumor-Immune Interactions. Int J Mol Sci 2021;22:3374. [PMID: 33806053 DOI: 10.3390/ijms22073374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Green S, Dam MS, Svendsen MN. Mouse avatars of human cancers: the temporality of translation in precision oncology. HPLS 2021;43. [DOI: 10.1007/s40656-021-00383-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
34 Sacco A, Battaglia AM, Botta C, Aversa I, Mancuso S, Costanzo F, Biamonte F. Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response. Cells 2021;10:303. [PMID: 33540645 DOI: 10.3390/cells10020303] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
35 Todorović-Raković N. The role of cytokines in the evolution of cancer: IFN-γ paradigm. Cytokine 2021;:155442. [PMID: 33509640 DOI: 10.1016/j.cyto.2021.155442] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
36 Fernando K, Kwang LG, Lim JTC, Fong ELS. Hydrogels to engineer tumor microenvironments in vitro. Biomater Sci 2021;9:2362-83. [DOI: 10.1039/d0bm01943g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Yan S, Fang J, Chen Y, Xie Y, Zhang S, Zhu X, Fang F. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer. BMC Cancer 2020;20:1205. [PMID: 33287740 DOI: 10.1186/s12885-020-07695-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
38 Dieterich LC, Bikfalvi A. The tumor organismal environment: Role in tumor development and cancer immunotherapy. Seminars in Cancer Biology 2020;65:197-206. [DOI: 10.1016/j.semcancer.2019.12.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
39 Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther 2020;5:166. [PMID: 32843638 DOI: 10.1038/s41392-020-00280-x] [Cited by in Crossref: 238] [Cited by in F6Publishing: 257] [Article Influence: 119.0] [Reference Citation Analysis]
40 Bocanegra A, Blanco E, Fernandez-Hinojal G, Arasanz H, Chocarro L, Zuazo M, Morente P, Vera R, Escors D, Kochan G. PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy. Int J Mol Sci 2020;21:E5918. [PMID: 32824655 DOI: 10.3390/ijms21165918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
41 Stavropoulos I, Sarantopoulos A, Liverezas A. Does sympathetic nervous system modulate tumor progression? A narrative review of the literature. J Drug Assess 2020;9:106-16. [PMID: 32939316 DOI: 10.1080/21556660.2020.1782414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 De Guillebon E, Dardenne A, Saldmann A, Séguier S, Tran T, Paolini L, Lebbe C, Tartour E. Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination. Int J Cancer 2020;147:1509-18. [DOI: 10.1002/ijc.32889] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
43 Rondeau E, Larmonier N, Pradeu T, Bikfalvi A. Characterizing causality in cancer. Elife 2019;8:e53755. [PMID: 31782731 DOI: 10.7554/eLife.53755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]